UTI Mutual Fund IPO (2020)

From WebNotes, a public knowledge base. Last updated . Reading time ~7 min.

The UTI Asset Management Company Limited IPO of October 2020 was the initial public offering of India’s oldest and historically most prominent asset management company, bringing to public markets an institution that traced its lineage to the Unit Trust of India Act of 1963. The IPO listed UTI AMC on both the National Stock Exchange of India and the Bombay Stock Exchange on 12 October 2020, at a price of Rs 500 per share, implying a market capitalisation of approximately Rs 6,357 crore at the time of listing. The offering followed the HDFC AMC IPO of 2018, which had established a market precedent for the valuation of asset-light fund management businesses in India.

Corporate background

UTI AMC was constituted as part of the bifurcation of the original Unit Trust of India following the UTI US-64 crisis of 2001 and the subsequent passage of the Unit Trust of India (Transfer of Undertaking and Repeal) Act, 2002. UTI AMC received the market-linked, NAV-compliant mutual fund schemes of the erstwhile UTI and was brought under the full regulatory jurisdiction of the Securities and Exchange Board of India from 1 February 2003.

The company was owned in equal 25-percent tranches by four public sector financial institutions: State Bank of India, Punjab National Bank, Bank of Baroda, and Life Insurance Corporation of India. This ownership structure, an artefact of the 2003 restructuring, meant UTI AMC had no single dominant private sector promoter and was effectively an institution governed by four institutional co-owners with divergent strategic interests, none of whom had the incentive to invest aggressively in the franchise.

Additionally, T. Rowe Price, the US-based asset management firm, held approximately 26 percent of UTI AMC through a stake built over 2010–2012, giving the company a credible international institutional shareholder with active asset management expertise.

Pre-IPO context

UTI AMC was the fourth-largest Indian AMC by AUM at the time of the IPO, managing approximately Rs 1.34 lakh crore across equity, debt, and hybrid schemes as of September 2020. However, the company had lost market share steadily through the 2010s as private sector AMCs, notably HDFC, ICICI Prudential, SBI, Aditya Birla Sun Life, and Nippon India (formerly Reliance), grew faster in both AUM and SIP market share.

Several factors constrained UTI AMC’s growth relative to peers: the multi-owner governance structure made strategic decision-making slower than at single-promoter AMCs; the legacy of the UTI US-64 crisis had permanently altered the brand perception of UTI among a generation of retail investors; and the institution had been slower than private sector competitors in building a technology-enabled direct investor platform and distributor engagement infrastructure.

SEBI had, since 2012, been applying pressure on PSU-linked AMCs to address overlapping ownership, four large PSU financial institutions each holding 25 percent stakes in UTI AMC created governance concerns about potential conflicts of interest in investment decision-making, particularly given that the same institutions sponsored their own competing AMCs (SBI Mutual Fund, Canara Robeco, PNB Principal, and others). An IPO was seen as a step toward rationalising the ownership structure.

IPO details

The IPO opened for subscription from 29 September to 1 October 2020.

ParameterDetail
Price bandRs 552–554 per share
IPO sizeApproximately Rs 2,152 crore (entirely offer-for-sale)
StructureEntirely offer-for-sale (OFS); no fresh issue component
Shares offeredApproximately 3.89 crore shares
Selling shareholdersSBI (1.52 crore), LIC (1.11 crore), Bank of Baroda (1.11 crore), T. Rowe Price (0.14 crore)
Listing date12 October 2020
Listing priceRs 500 per share (below issue price)

The IPO was entirely an offer-for-sale by existing shareholders, meaning UTI AMC itself raised no primary capital. All proceeds went to the selling shareholders. SBI, LIC, and Bank of Baroda each partially divested their stakes; T. Rowe Price divested a minor portion.

The issue was oversubscribed overall, though the qualified institutional buyer (QIB) portion attracted the strongest interest while the retail investor portion was subscribed modestly. The listing at Rs 500 per share, below the issue price of Rs 554, meant that IPO investors experienced a listing loss of approximately 10 percent.

Post-listing performance and strategic context

UTI AMC’s share price remained under pressure in the months following listing as the broader market reassessed the competitive dynamics of the Indian asset management industry. The company faced structural AUM growth challenges relative to its listed peers. Its equity AUM market share continued to gradually decline relative to private sector AMCs with stronger distributor relationships and brand equity.

The post-IPO period also witnessed significant management instability. The UTI AMC Chief Executive position saw multiple transitions, partly reflecting the difficulty of obtaining consensus among four PSU co-owners on strategic direction. SEBI’s governance guidelines for AMCs, which require the MD/CEO to be approved by the AMC board and trustees, provided a formal check but did not resolve the informal conflict among the four institutional shareholders.

T. Rowe Price’s continued presence as the largest non-PSU shareholder was significant. T. Rowe’s stake, consolidated at approximately 23 percent post-IPO, gave the UTI AMC board access to global asset management expertise and provided a commercial counterweight to the four PSU institutions in governance discussions.

Valuation and comparator analysis

At its listing price of Rs 500 per share, UTI AMC was valued at approximately Rs 6,357 crore, representing a price-to-earnings ratio of approximately 25–30 times trailing earnings, a significant discount to the HDFC AMC IPO valuation of 2018, which had listed at approximately 40–45 times earnings. The discount reflected several factors:

  • UTI AMC’s below-industry-average return on equity, attributable to its historically lower equity AUM share and the absence of a concentrated profitable equity franchise.
  • The governance complexity of a four-PSU-owner structure, which analysts viewed as likely to constrain the speed of business decision-making and strategic adaptation.
  • A perceived brand disadvantage relative to HDFC AMC and ICICI Prudential AMC in equity fund distribution, particularly in urban markets.
  • The subdued debut below issue price, which created an overhang as early investors who had subscribed at Rs 554 sought to exit.

The discount also reflected that UTI AMC was, at the time of IPO, not the highest-growth AMC in the industry. Its SIP market share was below its overall AUM market share, suggesting that net flows were concentrated in less profitable institutional and fixed-income mandates rather than the higher-margin retail equity and hybrid schemes that drove premium valuations for competitors.

UTI AMC’s NPS and PMS businesses

Beyond its mutual fund business, UTI AMC had two strategically significant adjacent operations: a portfolio management services (PMS) business serving high-net-worth clients, and a National Pension System (NPS) fund management mandate. UTI Retirement Solutions, a wholly owned subsidiary, was one of the PFRDA-registered pension fund managers operating under the NPS architecture. The NPS mandate, covering government employee pension accumulations, represented a large, captive, low-cost assets base that contributed to UTI’s overall AUM but generated thinner margins than retail equity mutual fund management.

The NPS business and the PMS operation were distinct revenue streams that supported the AMC’s case for a diversified financial services valuation, though their proportional contribution to earnings was smaller than the core open-end mutual fund business.

Significance

The UTI AMC IPO was significant in several respects. It completed the market visibility of the major Indian AMC sector, following the HDFC AMC IPO of 2018 and paving the way for Aditya Birla Sun Life AMC’s IPO in October 2021. Together, these listings allowed public market investors to own stakes in India’s fastest-growing financial sector segment and provided a price discovery mechanism for asset management business economics in an emerging market context.

The UTI listing also closed a chapter in the UTI US-64 crisis narrative. The institution that had required a Rs 14,500 crore government bailout in 2001 was now a SEBI-regulated, publicly listed company generating returns on equity comparable to its private sector peers, symbolising the successful regulatory transformation of India’s mutual fund sector.

Key dates

DateEvent
1 February 2003UTI AMC constituted under the 2002 Repeal Act
2010–2012T. Rowe Price builds approximately 26 percent stake
29 September–1 October 2020IPO subscription period
12 October 2020UTI AMC listed on NSE and BSE at Rs 500 per share

See also

Reviewed and published by

The WebNotes Editorial Team covers Indian capital markets, payments infrastructure and retail investor procedures. Every article is fact-checked against primary sources, principally SEBI circulars and master directions, NPCI specifications and the official support documentation published by the intermediary in question. Drafts go through a second-pair-of-eyes review and a separate compliance read before publication, and revisions are tracked against the SEBI and NPCI rule changes referenced in the methodology section.

Last reviewed
Conflicts of interest
WebNotes is independent. No relationship with any broker, registrar or bank named in this article.